Get Transformation of Human Epithelial Cells 1992 Molecular and Oncogenetic Mechanisms First Edition Casto PDF ebook with Full Chapters Now
Get Transformation of Human Epithelial Cells 1992 Molecular and Oncogenetic Mechanisms First Edition Casto PDF ebook with Full Chapters Now
Get Transformation of Human Epithelial Cells 1992 Molecular and Oncogenetic Mechanisms First Edition Casto PDF ebook with Full Chapters Now
com
https://textbookfull.com/product/transformation-
of-human-epithelial-cells-1992-molecular-and-
oncogenetic-mechanisms-first-edition-casto/
https://textbookfull.com/product/topology-and-physics-of-circular-
dna-1992-first-edition-vologodskii/
textbookfull.com
https://textbookfull.com/product/epithelial-cell-culture-methods-and-
protocols-methods-in-molecular-biology-2749-mario-baratta/
textbookfull.com
https://textbookfull.com/product/molecular-mechanisms-of-autonomy-in-
biological-systems-tara-karimi/
textbookfull.com
https://textbookfull.com/product/industry-innovation-and-
infrastructure-encyclopedia-of-the-un-sustainable-development-goals-
leal-filho/
textbookfull.com
https://textbookfull.com/product/instant-ext-js-starter-1st-edition-
bhava-nagarajan/
textbookfull.com
https://textbookfull.com/product/auctioned-to-the-bratva-bratva-mafia-
age-gap-romance-morozov-bratva-book-9-lexi-asher/
textbookfull.com
https://textbookfull.com/product/discretion-and-the-quest-for-
controlled-freedom-tony-evans/
textbookfull.com
Fiber Optics Physics and Technology 2nd Edition Fedor
Mitschke (Auth.)
https://textbookfull.com/product/fiber-optics-physics-and-
technology-2nd-edition-fedor-mitschke-auth/
textbookfull.com
Transformation
of
Human Epithelial Cells:
Editors
CRC
\CP* J Taylor & Francis Group
^***^/ Boca Raton London New York
This book contains information obtained from authentic and highly regarded sources.
Reasonable efforts have been made to publish reliable data and information, but the author
and publisher cannot assume responsibility for the validity of all materials or the consequences
of their use. The authors and publishers have attempted to trace the copyright holders of all
material reproduced in this publication and apologize to copyright holders if permission to
publish in this form has not been obtained. If any copyright material has not been
acknowledged please write and let us know so we may rectify in any future reprint.
Except as permitted under U.S. Copyright Law, no part of this book may be reprinted,
reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other
means, now known or hereafter invented, including photocopying, microfilming, and
recording, or in any information storage or retrieval system, without written permission from
the publishers.
For permission to photocopy or use material electronically from this work, please access www.
copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc.
(CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit
organiza-tion that provides licenses and registration for a variety of users. For organizations
that have been granted a photocopy license by the CCC, a separate system of payment has been
arranged.
Publisher's Note
The publisher has gone to great lengths to ensure the quality of this reprint but points out that
some imperfections in the original copies may be apparent.
Disclaimer
The publisher has made every effort to trace copyright holders and welcomes correspondence
from those they have been unable to contact.
Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com and the CRC Press
Web site at http://www.crcpress.com
PREFACE
Several years ago, in the 1960s and 1970s, there were but a few human
cell lines available to study human cell carcinogenesis. At that time the
"Hayflick" hypothesis suggested that human cells cultured in vitro have a
finite life-span of approximately 60 PDs; little was known of the "real"
relationship between the limited life-span of the human fibroblast in vitro and
aging in vivo. This area of research piqued the interest of the scientific
community because the expression of cancer was thought to be an escape of
the neoplastic phenotype from the limited proliferative potential, i.e., the
finite life-span. However, over the years many human cancers were deter-
mined to be of an epithelial origin, and it was not possible to isolate, except
on a rare occurrence, stable tumor phenotypes in vitro that exhibited infinite
life-spans. Consistently heterogenous human tumor phenotypes either ceased
to proliferate or terminally differentiated in vitro. Rarely did we observe in
a routine fashion an escape from a limited life-span to a phenotype with an
unrestricted proliferative potential. With the advent of collagen-coated plastic
substratum, feeder layers, "quasi"-chemically defined growth media con-
taining the likes of pituitary extracts, and growth factors, epithelial cells from
different human tissues could be isolated and cultured for limited defined
periods in vitro. Still the concept of the limited life-span of normal cells in
vitro persisted and the cancer cell was thought to be an escape from a limited
life-span. This loss of growth control and extension of life-span are discussed
in Chapter 5 by Johng S. Rhim, one of the pioneers in the field of SV-40T-
induced immortalization of human cells. We have included also a chapter on
another developing field that will dramatically impact the field of growth
control and life-span. Chapter 2 examines how autocrine and paracrine factors
elicit proliferative growth responses in normal and transformed cells. In the
1970s, Heppner recognized along with others that epithelial tumors were
heterogenous in cellular composition. Since that time we have learned how
to identify different phenotypes from the epithelial tumors. Because of the
recent achievements by Bert Vogelstein in the late 1980s of identifying, in
colon carcinoma tumors, cells that occupy different stages of progression and
the discovery by Patricia Steggs and Lance Liotta in the late 1980s of the
molecular events that were associated with expression of the metastatic stage,
we can now follow the events of metabolism of putative human carcinogens,
DNA-adduct binding, early, middle and late stages of progression of initiated
cells, anchorage-independent growth, identification of expression of altered
phenotypes, and identification of expression of tumorigenic and metastatic
phenotypes. If we agree that tumors are clonal in origin, then we need to
understand that tumor heterogeneity may be a function of the composition of
mixed phenotypes. Some of these questions comprise the reasons this book
and the contributors were assembled to address the stages from metabolism
to metastasis of epithelial cells associated with epithelial tumors.
In Chapter 1, James R. Smith addresses the role immortalization plays
in cancer and how resistant human cells are to spontaneous immortalization.
There has been an attempt to link the loss of expression of a finite life-span
to the change in genetic program of either the 1st or the 4th chromosome. A
defect in these chromosomes putatively can give rise to the expression of a
cellular phenotype that exhibits immortalization. However, at present (in these
authors' opinion) the question of quiescence vs. senescence in human cells
has not been answered by these experiments. The loss of senescent control
can lead to immortalization; the loss of control of expression of quiescence
cannot. However, it is recognized that the transient down-regulation of the
cyclin gene or the permanent interruption of this gene function may play a
pivotal role in the two processes. The next several chapters discuss the stages
of multi-stage carcinogenesis in different epithelial cell systems. Moreover,
correlative stages of progression in different carcinogen-transformed epithelial
cell systems are compared and contrasted. The last few chapters — 10, 11,
and 12 — discuss molecular controlling mechanisms that are involved in the
control of expression of stages of progression, e.g., the role of oncogenes
and their interactiveness with the suppressor genes. In particular, the role of
ras gene mutations and suppressor gene interaction with these activated on-
cogenes in tumorigenic cells in controlling the progression of initiated cells
into tumor cells is presented. The promotion stage in human cell carcino-
genesis is a silent stage and has not been observed experimentally, and many
attempts to discover this stage have led to failure.
In Chapter 13 we compare and contrast the stages from metabolism, DNA-
adduct formation, anchorage-independent tumor growth, and regression be-
tween epithelial cells and fibroblast (see also Transformation of Human Dip-
loid Fibroblast: Molecular and Genetic Mechanisms, Milo, G. E. and Casto,
B . C . , Eds., CRC Press, 1990). Lastly, an invitation was extended to Juergen
R. Vielkind to contribute a guest chapter discussion on the nature of growth
control in osteichthyes. Our reasons for including this chapter are to develop
and understand the biological significances of the conservation of suppressor
gene function phylogenetically from lower animals up to humans and to
understand the role of some of these genes in more primitive animal systems.
It was our intention to present to the scientific community a forum for
focusing on the utility of how human epithelial cells as systems can be used
to examine how environmental xenobiotics can be metabolized to reactive
metabolites that can react with critical sites on the genomic DNA that lead
to the expression of an early stage of a transformed phenotype. Later in the
book we have focused on how current dogma in suppressor gene-oncogene
interaction is insufficient to totally explain the existence of many diverse
phenotypes in a heterogenous spontaneous epithelial cell tumor. Moreover,
the concept of plasticity — the transient expression of a tumorigenic phen-
otype — is not explained only by the presence of mutations in critical sites
of activated oncogenes or mutations in suppressor genes. This treatise is an
attempt to collate many of the scientific results, significant scientific concepts,
and laboratory efforts from active investigators in this field of environmentally
induced human epithelial cell cancer.
George E. Milo
Bruce C. Casto
Charles F. Shuler
THE EDITORS
Chapter 1
In Vitro Cellular Aging and Immortalization 1
James R. Smith
Chapter 2
Detection of Growth Factor Effects and Expression in Normal and
Neoplastic Human Bronchial Epithelial Cells 13
Jill M. Siegfried, Michael J. Birrer, and Frank C. Cuttitta
Chapter 3
Human Cell Metabolism and DNA Adduction of Polycyclic Aromatic
Hydrocarbons 31
Hudson H. S. Lau and William M. Baird
Chapter 4
Human Esophageal Epithelial Cells: Immortalization and In Vitro
Transformation 67
Gary D. Stoner, Zenya Naito, and George E. Milo
Chapter 5
Transformation of Human Endometrial Stromal Cells In Vitro 85
Clifford A. Rinehart, Charleata A. Carter, Li Hui Xu, Linda L. Barrett,
Tammela Butler, Caroline H. Laundon, and David G. Kaufman
Chapter 6
Factors Influencing Growth and Differentiation of Normal and
Transformed Human Mammary Epithelial Cells in Culture 117
Martha R. Stampfer and Paul Yaswen
Chapter 7
Transformation of Colon Epithelial Cells 141
Dharam P. Chopra
Chapter 8
Multistep Carcinogenesis and Human Epithelial Cells 169
Johng S. Rhim
Chapter 9
Morphologic and Molecular Characterizations of Plastic Tumor Cell
Phenotypes 211
Charles F. Shuler and George E. Milo
Chapter 10
Oncogene and Tumor Suppressor Gene Involvement in Human Lung
Carcinogenesis 235
Teresa S. Lehman and Curtis C. Harris
Chapter 11
Events of Tumor Progression Associated with Carcinogen Treatment
of Epithelial and Fibroblast Compared with Mutagenic Events 261
George E. Milo and Bruce C. Casto
Chapter 12
Progression from Pigment Cell Patterns to Melanomas in Platyfish-
Swordtail Hybrids — Multiple Genetic Changes and a Theme for
Tumorigenesis 285
Juergen R. Vielkind
Index 303
Smith 1
Chapter 1
James R. Smith
TABLE OF CONTENTS
I. Introduction 2
IV. Discussion 9
References 10
2 Transformation of Human Epithelial Cells
I. INTRODUCTION
a hybrid that has finite proliferative potential. On the other hand, fusion of
cell lines having the same defect would not result in complementation and
would give rise to hybrids that could divide indefinitely. Therefore, we would
predict that hybrids resulting from fusions among different immortal cell lines
would give two different kinds of results. In one case, some hybrids would
have a finite life-span and the other hybrids would have an indefinite life-
span. In a series of experiments, Pereira-Smith and Smith fused different cell
lines with each other and observed the proliferative phenotype (either finite
or indefinite),19 and assigned more than 30 different cell lines to four different
complementation groups. In order to begin the process of complementation
group assignment, one SV40-transformed cell line was chosen at random to
be representative of complementation group A. Other cell lines were fused
with it. Those that had an indefinite proliferative potential also assigned to
complementation group A; those that had a finite proliferative potential as-
signed to a different complementation group. Using HeLa as a prototypic cell
line for complementation group B, we repeated the process and assigned cell
lines to complementation group B. Cell lines were assigned to other com-
plementation groups in a similar fashion. This process involved numerous
cell fusions, and in no case did we find a cell line that assigned to more than
one complementation group. This indicated that the processes resulting in
cellular immortality were very rare, with no cell lines carrying two different
defects. We looked at a large number of different cell lines resulting from
different kinds of tumors, different cell types of origin, cell lines derived
from different embryonic layers, and cell lines that contained activated on-
cogenes, and in no cases did these parameters affect complementation group
assignment. The only parameter that did affect assignment was immortali-
zation by the SV40 large T-antigen. Seven out of eight of the SV40-immor-
talized cell lines assigned to complementation group A. One of the SV40 cell
lines failed to assign to complementation group A. The reason for this is not
known. We can speculate that the SV40 T-antigen was not the actual im-
mortalizing agent in this case, but was only coincidental in the transformation
process. The assignment of cell lines to different complementation groups
allows us to take a systematic approach to trying to understand what processes
might have occurred to result in cellular immortalization. We speculate at the
present time that those cell lines which assign to the same complementation
group have become immortalized by the same genetic defect. The case for
this interpretation is strengthened by the fact that almost all of the SV40-
transformed immortalized cell lines fall into the same complementation group.
However, it appears that not all DNA tumor viruses immortalize cells by the
same mechanism, because we found that cell lines immortalized by adeno,
papilloma, and herpes virus fell into different complementation groups. Efforts
are currently underway to find the genetic defect that leads to immortalization
in the case of SV40 T-antigen.
6 Transformation of Human Epithelial Cells
A. HETEROKARYON EXPERIMENTS
One of the first experiments that gave us an idea of the kinds of processes
that might be responsible for cellular senescence was performed by Norwood
et al.24 and independently by Stein and Yanishevsky. 25 They fused senescent
cells that had reached the end of their in vitro life-span with normal cells that
were still able to proliferate and asked whether the nuclei contained in the
heterokaryon were able to synthesize DNA. When senescent cells were fused
with young cells, it appeared that the senescent cell was able to suppress the
initiation of DNA synthesis in the young cell nucleus, i.e., neither the young
cell nucleus nor the senescent cell nucleus synthesized DNA in the hetero-
karyons up to 72 h after fusion. However, if young cells were fused with
each other, there was no decrease in the ability of the young cell nuclei to
synthesize DNA in the homodikaryon. From these results, it was concluded
that senescent cells produce an inhibitor of DNA synthesis which is able to
act in trans to inhibit the initiation of DNA synthesis in the young nucleus.
Furthermore, it has been shown that senescent cells, when fused with various
Smith
immortal cell lines,25 suppress DNA synthesis in the nucleus of the immortal
cell. This indicates that the inhibitor produced by senescent cells is able to
also inhibit the initiation of DNA synthesis in certain immortal cell lines.
However, other immortal cell lines,26 in particular those that have been im-
mortalized by DNA tumor viruses, e.g., SV40-transformed cells of HeLa
cells (HeLa is known now to have part of the herpes virus DNA integrated
into its genome), are able to induce DNA synthesis, in the short term, in the
senescent cell nucleus. This indicates that although senescent cells produce
an inhibitor of DNA synthesis, it is possible, through the intervention of DNA
tumor viruses, to temporarily override this inhibitor.27
Yanishevsky and Stein showed that the inhibitor of DNA synthesis present
in senescent cells could not interrupt ongoing DNA synthesis, but acted to
block the initiation of DNA synthesis. They found that if senescent cells were
fused to young cells that were more than 3 or 4 h from the S-phase, then
initiation of DNA synthesis was blocked. If they were closer to the S-phase,
then initiation of DNA synthesis was not blocked.28
produced from senescent cells or cells from premature aging syndrome patients
will yield the inhibitor genes that are associated with cellular senescence.
Another approach to this problem is to produce monoclonal antibodies
by immunizing mice with surface membrane preparations from senescent
cells. We have isolated monoclonal antibodies in this way.38 Of approximately
6000 hybridoma cultures screened, three yielded antibodies that reacted pref-
erentially with senescent cells but not with young cells. All the antibodies
react with an epitope on the fibronectin molecule. Although they react with
fibronectin from various sources, when it is denatured, they only react with
fibronectin distributed on the surface of senescent cells, not with fibronectin
distributed on the surface of young cells. This indicates that senescent cells
are producing either a fibronectin that is altered in its primary structure or
posttranslationally modified in a way different from that of young cells. The
senescent cell-produced fibronectin would then have a different conformation
than that of young cells. Another possibility is that the fibronectin protein
produced by senescent cells and young cells is the same, but the interaction
of fibronectin with other molecules produced by senescent cells and young
cells is different, thus leading to an altered confirmation of fibronectin as-
sociated with senescent cells, exposing an epitope which is sequestered in
young cells.
IV. DISCUSSION
REFERENCES
1. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G., Cancer metastasis and
angiogenesis: an imbalance of positive and negative regulation, Cell, 64, 327, 1991.
2. Fearon, E. R. and Vogelstein, B., A genetic model for colorectal tumorigenesis, Cell,
61, 759, 1990.
3. O'Brien, W., Stenman, G., and Sager, R., Suppression of tumor growth by senescence
in virally transformed human fibroblasts, Proc. Natl. Acad. Sci. U.S.A., 1986, 83, 8659.
4. Hayflick, L. and Moorhead, P. S., The serial cultivation of human diploid cell strains,
Exp. Cell Res., 25, 585, 1961.
5. Hayflick, L., The limited in vitro lifetime of human diploid cell strains, Exp. Cell Res.,
37, 614, 1965.
6. Martin, G. M., Sprague, C. A., and Epstein, C. J., Replicative life-span of cultivated
human cells: effects of donor age, tissue, and genotype, Lab. Invest., 23, 86, 1970.
7. Norwood, T. H. and Smith, J. R., The cultured fibroblast-like cell as a model for the
study of aging, in Handbook of Biological Aging, Finch, C. E. and Schneider, E. L.,
Eds., Van Nostrand Reinhold, New York, 1985, 291.
8. Macieira-Coehlo, A., Implications of the reorganization of the cell genome for aging
or immortalization of dividing cells in vitro, Gerontology, 26, 276, 1980.
9. Meek, R. L., Bowman, P. D., and Daniel, C. W., Establishment of mouse embryo
cells in vitro. Relationship of DNA synthesis, senescence and malignant transformation,
Exp. Cell Res., 125, 453, 1977.
10. Rothfels, F. H., Kupelweiser, E. B., and Parker, R. C., Effects of x-irradiated feeder
layers on mitotic activity and development of aneuploidy in mouse embryo cells in vitro,
Can. Cancer Conf., 5, 191, 1963.
Smith 11
31. Pereira-Smith, O. M., Fisher, S. F., and Smith, J. R., Senescent and quiescent cell
inhibitors of DNA synthesis. Membrane-associated proteins, Exp. Cell Res., 160, 297,
1985.
32. Stein, G. H. and Atkins, L., Membrane-associated inhibitor of DNA synthesis in
senescent human diploid fibroblasts: characterization and comparison to quiescent cell
inhibitor, Proc. Natl. Acad. Sci. U.S.A., 83, 9030, 1986.
33. Lumpkin, C. K. J., McClung, J. K., Pereira-Smith, O. M., and Smith, J. R.,
Existence of high abundance antiproliferative mRNA's in senescent human diploid fi-
broblasts, Science, 232, 393, 1986.
34. Lumpkin, C. K. J., McClung, J. K., and Smith, J. R., Entry into S phase is inhibited
in human fibroblasts by rat liver poly(A) + RNA, Exp. Cell Res., 160, 544, 1985.
35. Nuell, M. J., Stewart, D. A., Walker, L., Friedman, V., Wood, C. M., Owens,
G. A., Smith, J. R., Schneider, E. L., Dell'Orco, R., Lumpkin, C. K., Danner,
D. B., and McClung, J. K., Prohibitin, an evolutionary conserved intracellular protein
that blocks DNA synthesis in normal fibroblasts and HeLa cells, Mol. Cell. Biol., 11,
1372, 1991.
36. Pepperkok, R., Schneider, C., Philipson, L., and Ansorge, W., Single cell assay
with an automated capillary microinjection system, Exp. Cell Res., 178, 369, 1988.
37. Pepperkok, R., Zanetti, M., King, R., Delia, D., Ansorge, W., Philipson, L., and
Schneider, C., Automatic microinjection system facilitates detection of growth inhibitory
mRNA, Proc. Natl. Acad. Sci. U.S.A., 85, 6748, 1988.
38. Porter, M. B., Pereira-Smith, O. M., and Smith J. R., Novel monoclonal antibodies
identify antigenic determinants unique to cellular senescence, J. Cell Physiol., 142, 425,
1990.
39. Seshadri, T. and Campisi, J., Repression of c-fos transcription and an altered genetic
program in senescent human fibroblasts, Science, 247, 205, 1990.
40. Stein, G. H., Drullinger, L. F., Robetorye, R. S., Pereira-Smith, O. M., and Smith,
J. R., Senescent cells fail to express the cdc2 gene in response to mitogen stimulation,
submitted.
41. Stein, G. H., Beeson, M., and Gordon, L., Failure to phosphorylate the retinoblastoma
gene product in senescent human fibroblasts, Science, 249, 666, 1990.
Random documents with unrelated
content Scribd suggests to you:
The Project Gutenberg eBook of Sexual ethics
This ebook is for the use of anyone anywhere in the United States
and most other parts of the world at no cost and with almost no
restrictions whatsoever. You may copy it, give it away or re-use it
under the terms of the Project Gutenberg License included with this
ebook or online at www.gutenberg.org. If you are not located in the
United States, you will have to check the laws of the country where
you are located before using this eBook.
Language: English
WITH INTRODUCTION
BY
LONDON
THE NEW AGE PRESS
140 FLEET STREET
1908
Translated from the German by Ashley Dukes
INTRODUCTION
By Dr. C. W. SALEEBY, F.R.S. Edin.
From the above brief sketch, which is based upon the theory of
evolution and the researches of science, it is clear as the day that
moral laws can only be relative. They were always relative to the
family, to the tribe, to the fatherland; they must become relative to
mankind. The racial (that is, inherited and instinctive) social sense in
man is unfortunately very variable in individual cases. In the average
it is extremely weak and chiefly directed towards a few individuals.
Moreover, as the result of centuries of bad habits and ancient
prejudices, its objects are falsely or unsuitably taught in process of
educating children. Instead of the child’s sense of duty being
directed to the necessity of labour and social sacrifice for mankind as
a whole and posterity in particular, it is directed towards false codes
of honour, local patriotism, family exclusiveness, private property,
pretended divine commandments, and so forth.
The Earth is small, and human intercourse becomes more
extensive every year; the union of all civilised peoples into a single
great civilised community is inevitable. Ethics must, therefore, as far
as reason permits, be directed towards this object. We require